ÄãºÃ£¬»¶Ó­À´µ½¾­¹ÜÖ®¼Ò [µÇ¼] [×¢²á]

ÉèΪÊ×Ò³ | ¾­¹ÜÖ®¼ÒÊ×Ò³ | Êղر¾Õ¾

0.5%ÂÞßß¿¨ÒòÑüÓ²ÁªºÏÂé×íÔڸس¦ÊÖÊõµÄÁÙ´²Ó¦ÓÃ_ÁÙ´²Ò½Ñ§×¨Òµ±ÏÒµÂÛÎÄ

·¢²¼Ê±¼ä£º2015-02-04 À´Ô´£ºÈË´ó¾­¼ÃÂÛ̳
0.5%ÂÞßß¿¨ÒòÑüÓ²ÁªºÏÂé×íÔڸس¦ÊÖÊõµÄÁÙ´²Ó¦ÓÃ_ÁÙ´²Ò½Ñ§×¨Òµ±ÏÒµÂÛÎÄ ¹Ø¼ü´Ê£ºÂÞßß¿¨Òò£»²¼±È¿¨Òò£»ÑüÂé-ӲĤÍâÁªºÏÂé×í ÖÐͼ·ÖÀàºÅ£ºR614 ÕªÒª£ºÄ¿µÄ ¹Û²ì0.5%ÂÞßß¿¨ÒòÑüÓ²ÁªºÏÂé×íÔڸس¦ÊÖÊõµÄÓ¦Óü°Êõºó»Ö¸´Çé¿ö¡£·½·¨ Ëæ»úÑ¡È¡ÔñÆÚÐиس¦ÊÖÊõµÄ»¼Õß48Àý,·ÖΪ2×é,ÂÞßß¿¨Òò£¨RP£©×éºÍ²¼±È¿¨Òò£¨×飩£¬ÑüÓ²ÁªºÏÂé×íÏÂ,ÖëÍøĤÏÂÇ»¸øÒ©¡£RP×éÖëÍøĤÏÂÇ»×¢Èë0.5%ÂÞßß¿¨Òò2ml£¬BP×é×¢Èë0.5%²¼±È¿¨Òò2ml¡£½á¹û RP×éµÄ¸Ð¾õ×èÖÍÓëÔ˶¯×èÖ͵ÄÆðЧʱ¼ä¾ùÂýÓÚBP×飬×î¸ß¸Ð¾õ×èÖÍƽÃæÓë×î´óÔ˶¯×èÖͳ̶ȾùµÍÓÚBP×飬¸Ð¾õ×èÖͳÖÐøʱ¼äÓëBP×éÎÞ²îÒ죬Ô˶¯×èÖͳÖÐøʱ¼äÔò¶ÌÓÚBP×é¡£2×黼Õß¾ùδÓÚӲĤÍâÇ»×·¼ÓÒ©Î¾ù°²È«ÂúÒâÍê³ÉÊÖÊõ¡£½áÂÛ 0.5%ÂÞßß¿¨ÒòÑüÓ²ÁªºÏÂé×íÊǸس¦¿ÆÊÖÊõ°²È«¿É¿¿µÄÂé×íÑ¡Ôñ¡£ The clinical use of 0.5% ropivacaine of combined spinal epidural anaesthesia in the anus intestine disease operation Abstract:Aim To investigate the clinical use of 0.5% ropivacaine of combined epidural anaesthesia in the anus intestine disease operation.Methods 48 patients who had anus intestine disease were randomly assigned to 2 groups(24 patients in every group):ropivacaine(RP) group and bupivacaine(BP) group,using combined epidural anaesthesia,ropivacaine and bupivacaine were injected into subarachnoind.Using 0.5% ropivacaine 2ml spinal anaesthesia in RP group and 0.5% bupivacaine 2ml in BP group.Results The oneset time of sensory and motor blocks in RP group were longer than that of BP group,the height of sensory block and the degree of motor block in RP group were lower than that of BP group, the duration of motor block in RP was shorter than that of BP,the duration of sensory block of the two groups were not siginificantly different.All patients were not used epidural anaesthesia additionally and completed surgery safely and satisfactorily.Conclusion 0.5% ropivacaine of combined epidural anaesthesia is the safe choice in the anus intestine disease operation Key words:ropivacaine;bupivacaine; combined spinal epidural anaesthesia ±¾ÊµÑéÑ¡ÓÃ0.5%ÂÞßß¿¨ÒòÓ¦ÓÃÓÚÑüÓ²ÁªºÏÂé×í£¬¹Û²ìÆä¶Ô¸ØÃÅ»áÒõÇø×èÖÍÍêÉƳ̶ȣ¬Æ½ÃæµÄÀ©É¢£¬×î´ó×èÖÍƽÃ棬×î´ó×èÖÍʱ¼ä£¬²¢Óë²¼±È¿¨ÒòÏà±È½Ï£¬ÎªÁÙ´²¸Ø³¦ÊÖÊõÂé×íÑ¡ÓÃÒ©ÎïÌṩÀíÂÛÒÀ¾Ý¡£ 1.ÁÙ´²×ÊÁÏ 1.11°ã×ÊÁÏ Ëæ»úÑ¡Ôñ¸Ø³¦¿ÆÊÖÊõ»¼Õß48Àý£¬ÄêÁä20¡«70Ë꣬ASA¢ñ¡«¢ò£¬ÅųýÌåÖÊÁ¿£¼40Kg£¬£¾100KgÕß¡£Ëæ»ú½«»¼Õß·Ö³ÉÂÞßß¿¨Òò×飨RP£©¡¢²¼±È¿¨Òò×飨BP£©£¬Ã¿×é24Àý¡£RP×飺10g/LÂÞßß¿¨Òò1ml+9g/LNaCl1mlÅä³É0.5%ÂÞßß¿¨ÒòÇá±ÈÖØÒº£»BP×飺0.5%²¼±È¿¨ÒòÈÜÒº2ml¡£ 1.2Âé×í·½·¨ »¼ÕßÈëÊÒ½¨Á¢¾²ÂöͨµÀÊä×¢ÁÖ¸ñʽҺ,¼à²âѪѹ¡¢Ðĵçͼ¡¢ÐÄÂÊ¡¢ÑªÑõ±¥ºÍ¶È£¬È¡×ó²àÎÔ룬Ñü3-4¼ä϶´©´Ì£¬ÄÔ¼¹ÒºÁ÷³öºó£¬ÒÔ0.1ml/sËٶȷֱðÍÆ×¢0.5%ÂÞßß¿¨ÒòÒº»ò0.5%²¼±È¿¨ÒòÈÜÒº2ml¡£Ö®ºóÏòÉÏÖÃÈëӲĤÍâµ¼¹Ü3cm¡£¹Û²ì²¢¼Ç¼ÉúÃüÌåÕ÷¼°Âé×íƽÃæ¡£ 1.3¼à²âÖ¸±ê Õë´Ì·¨²âÊԸоõ×èÖÍƽÃ棬¸ÄÁ¼Bromage·¨[1]ÆÀ¶¨Ô˶¯×èÖÍ¡£30minÄÚÿ¸ô2.5min²â¶¨1´Î£¬ÒÔºóÿ¸ô15min²â¶¨1´Î£¬Ö±ÖÁ¸Ð¾õºÍÔ˶¯ÍêÈ«»Ö¸´¡£·Ö±ð¼Ç¼¸Ð¾õ×èÖÍÆðЧʱ¼ä¡¢×î¸ß¸Ð¾õ×èÖÍƽÃæ¡¢¸Ð¾õ×èÖͳÖÐøʱ¼ä£¬Ô˶¯×èÖÍÆðЧʱ¼ä£¬×î´óÔ˶¯×èÖͳ̶ȣ¨BromageÆÀ·Ö£©¡¢Ô˶¯×èÖͳÖÐøʱ¼ä¡£ 1.4 ͳ¼Æѧ´¦Àí Êý¾ÝÓþùÊý¡À±ê×¼²î±íʾ£¬£¬²ÉÓÃspss11.5ͳ¼ÆÈí¼þ°ü½øÐÐÊý¾Ý´¦Àí£¬×é¼ä±È½Ï²ÉÓÃStudent¡¯s-t¼ìÑ飬¦Á=0.05¡£ 2.½á¹û RP×éµÄ¸Ð¾õ×èÖÍÓëÔ˶¯×èÖ͵ÄÆðЧʱ¼ä¾ùÂýÓÚBP×飬×î¸ß¸Ð¾õ×èÖÍƽÃæÓë×î´óÔ˶¯×èÖͳ̶ȾùµÍÓÚBP×飬¸Ð¾õ×èÖͳÖÐøʱ¼äÓëBP×éÎÞ²îÒ죬Ô˶¯×èÖͳÖÐøʱ¼äÔò¶ÌÓÚBP×飨¼û±í1¡¢±í2£©¡£2×黼Õß¾ùδÓÚӲĤÍâÇ»×·¼ÓÒ©Î¾ù°²È«ÂúÒâÍê³ÉÊÖÊõ¡£ ±í1 RP×éºÍBP×é¸Ð¾õ×èÖÍ±È½Ï ×é±ð ¸Ð¾õ×èÖÍÆðЧʱ¼ä ×î¸ß¸Ð¾õ×èÖÍƽÃæ ¸Ð¾õ×èÖͳÖÐøʱ¼ä £¨min£© ÐØ×µ¼¹Ëè½Ú¶Î £¨min£© RP×é 4¡À1.4* 11.8¡À0.8 * 289¡À83 BP×é 1.6¡À0.5 10¡À1.5 288¡À51 ×é¼ä±È½Ï²ÉÓÃstudent¡¯-t¼ìÑ飬*P0.05 ±í2 RP×éºÍBP×éÔ˶¯×èÖÍ±È½Ï ×é±ð Ô˶¯×èÖÍÆðЧʱ¼ä ×î´óÔ˶¯×èÖÍ³Ì¶È Ô˶¯×èÖͳÖÐøʱ¼ä £¨min£© BromageÆÀ·Ö £¨min£© RP×é 11¡À3* 1.9¡À1.4* 118¡À36* BP×é 3¡À1.3 3¡À0 208¡À67 ×é¼ä±È½Ï²ÉÓÃstudent¡¯-t¼ìÑ飬*P0.05 3. ÌÖÂÛ ÂÞßß¿¨ÒòÊÇ1ÖÖеÄõ£°·Àà¾ÖÂéÒ©,ÓйØËüÓÃÓÚÑüÂéµÄЧ¹û¼°°²È«ÐÔ,Âé×í¹¤×÷Õß×öÁË´óÁ¿µÄÑо¿Óë̽ÌÖ¡£ÓÐÑо¿±íÃ÷[2]70.5%ÂÞßß¿¨ÒòÓ¦ÓÃÓÚÑüÂ鰲ȫ¡¢¿É¿¿¡¢ÓÐЧ,²»Á¼·´Ó¦ÉÙ¡£KallioµÈ[3]]Ñо¿½á¹ûÏÔʾ£ºÂÞßß¿¨Òò×èÖ͸оõÉñ¾­µÄʱ¼äÊDz¼±È¿¨ÒòµÄ2/3£¬×èÖÍÔ˶¯Éñ¾­µÄʱ¼äÊDz¼±È¿¨ÒòµÄ1/2;¶ÔÔ˶¯Éñ¾­µÄ×èÖÍÄÜÁ¦ÊDz¼±È¿¨ÒòµÄ1/2¡£Ô˶¯Éñ¾­ÍêÈ«»Ö¸´µÄʱ¼äÓëÂÞßß¿¨ÒòµÄÓÃÁ¿Ö®±ÈÊÇ10min/mg ¡«10.5min/mg¡£µ«ÊÇÒ²ÓÐЩѧÕßµÄÑо¿Óë´ËÓÐÉÙÐí²îÒì¡£GautierµÈ[4]Ñо¿½á¹ûÏÔʾÂÞßß¿¨Òò¶ÔÔ˶¯Éñ¾­µÄ×èÖÍÄÜÁ¦ÊDz¼±È¿¨ÒòµÄ2/3£»¶øMalinovskyµÈ[5]µÄÑо¿½á¹ûÏÔʾÂÞßß¿¨Òò¶ÔÔ˶¯Éñ¾­µÄ×èÖÍÄÜÁ¦ÊDz¼±È¿¨ÒòµÄ3/4¡£±¾Ñо¿½á¹ûÏÔʾ£ºRP×é×î´ó¸Ð¾õÓëÔ˶¯×èÖͳ̶ȾùµÍÓÚBP×飬Ô˶¯×èÖͳÖÐøʱ¼äµÍÓÚBP×é¡£ÓëÉÏÊöÑо¿½á¹ûÏàËÆ¡£¶ø±¾ÊµÑéÖÐÏÔʾRP×éÓëBP×éµÄ¸Ð¾õ×èÖͳÖÐøʱ¼äÎÞ²îÒ죬ÓëÉÏÊöµÄÑо¿½á¹û²»Í¬£¬¿ÉÄÜÊDZ¾ÊµÑéÓëÉÏÊöʵÑéµÄ´©´ÌÌåλ¡¢´©´Ì¼ä϶ÒÔ¼°Ò©Òº×é³ÉÂÔÓв»Í¬Ôì³ÉµÄ¡£²¢ÇÒ±¾ÊµÑéÏÔʾ£ºRP×éÎÞÂ۸оõ×èÖÍ»¹ÊÇÔ˶¯×èÖ͵ÄÆðЧʱ¼ä¾ùÂýÓÚBP×é¡£ÔÚ±¾ÊµÑéÖУ¬»¼ÕßÑ­»·Îȶ¨£¬¸Ð¾õÊæÊÊ¡¢¸ØÖܼ¡ÈâËɳÚÁ¼ºÃ,ÊÖÊõÒ½ÉúÂúÒâ¡£ËäÈ»RP×éµÄ×î´ó¸Ð¾õ×èÖÍƽÃæµÍÓÚBP×飬µ«ÊÇÍêÈ«Äܹ»Âú×ã¸Ø³¦¿ÆÊÖÊõÐèÒª£¬ÇÒ²»ÐèӲĤÍâÇ»×·¼Ó¸øÒ©£¬Òò´Ë0.5%ÂÞßß¿¨ÒòÑüÓ²ÁªºÏÂé×íÊǸس¦ÊÖÊõ°²È«¿É¿¿µÄÂé×íÑ¡Ôñ¡£ ²Î¿¼ÎÄÏ× 1. ÍõÑÞæ­£¬ÖÜ´ºÑ࣬Íõ·². Âޱȿ¨ÒòºÍ²¼±È¿¨ÒòÔÚÓ²¼¹Ä¤Íâ×èÖÍÖеÄÓ¦ÓÃ.¼ªÁÖ´óѧѧ±¨(ҽѧ°æ)2002,5:550-552. 2.ФÉÙ»ª,ÂÞÕñÖÐ,ÏÄÃôµÈ. ÂÞßß¿¨ÒòÓë²¼±È¿¨ÒòÓÃÓÚÖëÍøĤÏÂÇ»×èÖ͵ÄÁÆЧ±È½Ï.Ò½Ò©µ¼±¨2005,1:43-44. 3.Kallio H,Snall EV T,Kero MP,et al.A comparison of intrathecal plain solutions containing ropivacaine 20 or 15 mg versus bupivacaine 10 mg.Anesth Analg,2004,99(3):713¨C717. 4.Gautier PE,De Kock M,Van Steenberge A,et al.Intrathecal ropivacaine for ambulatory surgery:a comparison between intrathecal bupivacaine and intrathecal ropivacaine for knee arthroscopy.Anesthesiology,1999,91(5):1239¨C1245. 5.Malinovsky JM,Charles F,Kick O,et al.Intrathecal anesthesia:ropivacaine versus bupivacaine.Anesth Analg,2000,91(6):1457¨C1460.
¾­¹ÜÖ®¼Ò¡°Ñ§µÀ»á¡±Ð¡³ÌÐò
  • ɨÂë¼ÓÈë¡°¿¼ÑÐѧϰ±Ê¼ÇȺ¡±
ÍƼöÔĶÁ
¾­¼ÃѧÏà¹ØÎÄÕÂ
±êÇ©ÔÆ
¾­¹ÜÖ®¼Ò¾«²ÊÎÄÕÂÍƼö